【24h】

CYTOTOXIC AND IMMUNOMODULATORY ACTIVITES OF POLYMER-BOUND DRUGS

机译:聚合物结合药物的细胞毒性和免疫调节酶活性

获取原文

摘要

Water-soluble synthetic polymers based on N-(2-hydroxypropyl) methacrylamide have been developed as drag carriers to improve the therapeutic index of a variety of anti-tumor agents and the immunosuppressive drug cyclosporin A [1]. HPMA copolymer is a biocompatible, non-immunogenic, non-toxic and targetable carrier to which drugs are bound covalently via a peptidyl spacer, usually Gly-Phe-Leu-Gly. Once the drug is covalently bound to the polymeric backbone, via a tetrapeptide spacer it becomes biologically inactive and non-toxic.
机译:基于N-(2-羟丙基)甲基丙烯酰胺的水溶性合成聚合物作为阻力载体,以改善各种抗肿瘤剂和免疫抑制药物环孢菌素A的治疗指数[1]。 HPMA共聚物是一种生物相容性的,非免疫原性,无毒,无毒的载体,其用肽基间隔物共价共价,通常是甘氨酸氏乳膏。一旦药物与聚合物骨架共价结合,通过四肽间隔件将其变得生物惰性无效和无毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号